GlassScriptPhysician profile
John M Leschke
NPI 1164798393
$7,652.68
in general payments reported to CMS, 2019-2025
10 companies · $1,493 in 2025
The $1,493 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $940 · 2022: $3,215 · 2023: $19.46 · 2024: $1,986 · 2025: $1,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,241 · Food and Beverage: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,240.68 |
| Food and Beverage | $1,257.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $4,094.80 | 2022-2024 | Teligen |
| Medtronic, INC. | $1,299.03 | 2021-2024 | Catalyft Pl Expandable Interbody System, Mazor X System |
| Arthrex, INC. | $1,259.46 | 2025 | |
| True North Surgical INC | $791.57 | 2024-2025 | |
| Depuy Synthes Sales INC. | $96.28 | 2024 | Teligen, Acf, Skyline |
| Biocomposites INC | $35.29 | 2024 | |
| Globus Medical, INC. | $21.33 | 2024 | Excelsiusgps Robotic Navigation System |
| Solventum Corporation | $20.63 | 2025 | Prevena, V.A.C. Granufoam |
| Stryker Corporation | $19.46 | 2023 | Universal Neuro 3, Na, Duramatrix |
| Ethicon US, LLC | $14.83 | 2025 | Surgiflo Hemostatic Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Leschke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.